About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Trans Nasal Insufflation for the Treatment of Snoring

NCT00832026·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Johns Hopkins University

Age

21–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Consenting adults over the age of 21
Diagnosed obstructive sleep apnea

You may not be if

Unstable cardiovascular disease
Uncontrolled hypertension (BP \> 190/110)
Severe intrinsic lung diseases (supplemental O2 \> 2 L/min during the day)
History of chronic renal insufficiency
History of hepatic insufficiency
Pregnancy
Bleeding disorders or Coumadin use
Sleep Disorders other than Obstructive Sleep Apnea (OSA)
Tracheostomy
Allergy to lidocaine

The record

StatusCompleted

PhaseNo phase

Taking part11

StartedJul 2004

UpdatedMay 12, 2023

Conditions

Obstructive Sleep Apnea

Where1

Johns Hopkins University
Baltimore, Maryland, United States

Clareo Health | Trans Nasal Insufflation for the Treatment of Snoring